Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Arteriosclerosis, Thrombosis, and Vascular Biology Année : 2020

Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent

Résumé

OBJECTIVE: TSP-1 (thrombospondin 1) is one of the most expressed proteins in platelet α-granules and plays an important role in the regulation of hemostasis and thrombosis. Interaction of released TSP-1 with CD47 membrane receptor has been shown to regulate major events leading to thrombus formation, such as, platelet adhesion to vascular endothelium, nitric oxide/cGMP (cyclic guanosine monophosphate) signaling, platelet activation as well as aggregation. Therefore, targeting TSP-1:CD47 axis may represent a promising antithrombotic strategy. APPROACH AND RESULTS: A CD47-derived cyclic peptide was engineered, namely TAX2, that targets TSP-1 and selectively prevents TSP-1:CD47 interaction. Here, we demonstrate for the first time that TAX2 peptide strongly decreases platelet aggregation and interaction with collagen under arterial shear conditions. TAX2 also delays time for complete thrombotic occlusion in 2 mouse models of arterial thrombosis following chemical injury, while Thbs1 −/− mice recapitulate TAX2 effects. Importantly, TAX2 administration is not associated with increased bleeding risk or modification of hematologic parameters. CONCLUSIONS: Overall, this study sheds light on the major contribution of TSP-1:CD47 interaction in platelet activation and thrombus formation while putting forward TAX2 as an innovative antithrombotic agent with high added-value.
Fichier principal
Vignette du fichier
Revised_manuscript_Jeanne_et_al_v2_MANUSCRIPT_TEXT.pdf (341.23 Ko) Télécharger le fichier
Figure_1.pdf (113.59 Ko) Télécharger le fichier
Figure_2.pdf (68.47 Ko) Télécharger le fichier
Figure_6.pdf (83.5 Ko) Télécharger le fichier
Revised_Figure_3.pdf (78.2 Ko) Télécharger le fichier
Revised_Figure_4.pdf (303.99 Ko) Télécharger le fichier
Revised_Figure_5.pdf (320.63 Ko) Télécharger le fichier
Revised_suppl_materials_Jeanne_et_al.pdf (1.43 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03357967 , version 1 (01-10-2021)

Identifiants

Citer

Albin Jeanne, Thomas Sarazin, Magalie Charlé, Charlotte Kawecki, Alexandre Kauskot, et al.. Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent. Arteriosclerosis, Thrombosis, and Vascular Biology, 2020, 41, pp.e1-e17. ⟨10.1161/ATVBAHA.120.314571⟩. ⟨hal-03357967⟩
114 Consultations
52 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More